Indogulf Cropsciences Limited
IPO Details
Subscription
Lot Distribution
Reservation
Company Fin.
₹18(16.22%)
Premium (ELP)
The Initial Public Offering of Indogulf Cropsciences Limited's culminated in its successful listing on Jul 03, 2025 at the NSE, BSE trading platform. The company secured 1,80,18,017 Shares through this capital market exercise, with 1,44,14,414 Shares allocated to new capital formation and ₹40.00 Cr to existing shareholder liquidity.
Investors participated within the price parameters of ₹105 to ₹111, with minimum investment requirements of 135 shares. The subscription period from Jun 26, 2025 to Jun 30, 2025 witnessed active investor engagement across categories.
Following the subscription closure, share allotment was processed on Jul 01, 2025. The subsequent listing established a public market for the company's shares, enabling price discovery and secondary market trading for investors.
Investors can bid starting from the minimum lot size specified for this IPO, and only in multiples of that lot size. The table below shows the minimum and maximum investment for retail investors and HNIs in terms of lots, quantity, and amount.
Indogulf Cropsciences Limited, established in 1993, is an Indian company involved in the production of crop protection products, plant nutrients, and biologicals. In 2019, it began manufacturing Spiromesifen technical with 96.5% purity and became one of the first local producers of Pyrazosulfuron Ethyl technical with 97% purity. The company operates four manufacturing units spread across approximately twenty acres in Samba (Jammu & Kashmir) and Nathupur and Barwasni in Haryana. It has a strong sales presence in 22 Indian states and 3 Union Territories, supported by 169 business partners, 5,772 distributors, and 129 international partners across 34 countries. Its flexible and multi-purpose production facilities allow it to adapt quickly to different customer needs. The company benefits from high entry barriers in the agrochemical sector, such as high costs and complex regulatory approvals. Indogulf's product range includes plant nutrients like specialty fertilizers and soil health products that improve fertility, root growth, and crop yield. Its crop protection offerings consist of insecticides, fungicides, herbicides, and bio-stimulants that help protect crops from pests, diseases, and weeds. The company also provides biologicals such as bio-fertilizers and bio-stimulants to enhance nutrient uptake, stress tolerance, and sustainable farming. Popular products in this category include Biogold, Indo Breeza, and Indo Mychoriza. As of August 31, 2024, the company employed 640 permanent staff members.
Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."
- Strong Domestic & Global Distribution – Present in 22 states, 3 UTs, and 34 countries with 5,700+ distributors and 169 partners.
- In-House Manufacturing Advantage – Facilities in J&K and Haryana offer better control over quality, cost, and supply chain.
- Advanced R&D and Innovation – Known for developing products like Spiromesifen, backed by strong technical research and innovation.
- Quality Control Risk – Any failure to meet quality standards may cause order losses, customer distrust, and impact revenue.
- Brand Reputation Risk – Negative publicity or product issues can harm brand image and reduce market share.
- Low Capacity Utilization Risk – Unused production capacity can raise costs and lower profits, affecting growth.
1. Om Prakash Aggarwal
2. Sanjay Aggarwal
3. Anshu Aggarwal
4. Arnav Aggarwal
Indogulf Cropsciences Limited
Bigshare Services Private Limited